Dawn Pingxi Lau
YOU?
Author Swipe
View article: 99P Pre-analytical barriers to successful molecular profiling
99P Pre-analytical barriers to successful molecular profiling Open
View article: 112P Sequencing post osimertinib with liquid biopsy to assess TKI resistance in patients with advanced EGFR-mutant NSCLC (SOLITAIRE study)
112P Sequencing post osimertinib with liquid biopsy to assess TKI resistance in patients with advanced EGFR-mutant NSCLC (SOLITAIRE study) Open
View article: A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC) Open
View article: Concurrent Single-Cell RNA and Targeted DNA Sequencing on an Automated Platform for Comeasurement of Genomic and Transcriptomic Signatures
Concurrent Single-Cell RNA and Targeted DNA Sequencing on an Automated Platform for Comeasurement of Genomic and Transcriptomic Signatures Open
BACKGROUND The comeasurement of both genomic and transcriptomic signatures in single cells is of fundamental importance to accurately assess how the genetic information correlates with the transcriptomic phenotype. However, existing techno…
View article: P2.13-21 MET Addiction Can be Circumvented Through EGFR Inhibition Via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLCX.
P2.13-21 MET Addiction Can be Circumvented Through EGFR Inhibition Via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLCX. Open
View article: A chemical genetics approach to identify therapeutic vulnerabilities in Gefitinib resistant, EGFR T790M
A chemical genetics approach to identify therapeutic vulnerabilities in Gefitinib resistant, EGFR T790M Open